Skip to main content
. 2023 Apr 13;24(8):7228. doi: 10.3390/ijms24087228
AChE Acetylcholinesterase
AD Alzheimer’s disease
Al Aluminium
ALS Amyotrophic lateral sclerosis
ANN Artificial neuronal network
ASD Autism spectrum disorder
ATSDR Agency for Toxic Substances and Disease Registry
AUD Alcohol use disorder
Bax Bcl-2-associated X protein
BBB Blood-brain barrier
Bcl-2 B-cell lymphoma 2
BMP-2 Bone morphogenic protein 2
Bw Body weight
CAE Ethanolic extract of Centella asiatica
Cal/OSHA California’s Division of Occupational Safety and Health
CAT Catalase
CCC Criteria chronic concentration;
CMC Criteria maximum concentration
CSF Cerebro-spinal fluid
CSN Central nervous system
Cu Copper
CuZnSOD Copper-zinc SOD
cyt c cytochrome c
DA Dopamine
Daergic dopaminergic
DE Dialysis encephalopathy
DFO Deferoxamine
EDTA Ethylenediaminetetraacetic acid
EFSA European Food Safety Authority
EPA Environmental Protection Agency
Fe Iron
GPx glutathione peroxidase
Hg Mercury
LOAEL Lowest-observed-adverse-effect level
MDA Malondialdehyde
Mn Manganese
MnSOD Manganese SOD
MS Multiple sclerosis
NFTs Neurofibrillary tangles
NIOSH The National Institute for Occupational Safety and Health
NOAEL No-observed-adverse-effect level
NOS Not otherwise specified
OSHA Occupational Safety and Health Administration
p53 Tumor protein 53
Pb Lead
PD Parkinson’s disease
PEL Permissible exposure limit
PTWI provisional tolerable weekly intake
REL recommended exposure limit
SCCS Scientific Committee on Consumer Safety
SCHEER Scientific Committee on Health, Environmental and Emerging Risks
Si Silicon
SNc Substantia nigra pars compact
SOD Superoxide dismutase
TBARS Thiobarbituric acid reactive substances
Tf Transferrin
TfR Transferrin receptor
TGF-ꞵ1 Transforming grow factor beta 1
TH Tyrosine hydroxylase
TNFα Tumor necrosis factor alpha
TWA Time weighted average
TWI Tolerable weekly intake
VTA Ventral tegmental area
WHO World Health Organization
Zn Zinc